The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data from the ninth wave of the survey was analyzed to find out more about the prevalence of polypharmacy in different countries and to break down which factors are associated with it.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Casuistry
Chronic eosinophilic pneumonia in RA
- Case Study: Secondary Pseudohypoaldosteronism
Severe electrolyte imbalances and nonspecific symptoms in an infant
- CKD and High Blood Pressure
Keeping an Eye on Bidirectional Interactions
- Molecular Classification, FIGO 2023, and Chemoimmunotherapy
Endometrial carcinoma
- Psoriatic Arthritis
Older patients at risk for tachyarrhythmias
- Genetic Kidney Disease: DOUBLE PROTECT Alport
The SGLT-2 inhibitor dapagliflozin as an add-on to RAS blockade
- Case Study: Cystic Fibrosis in Adults
Recurrent Pneumonia as a Manifestation of Cystic Fibrosis
- Long COVID/Fatigue Clinic